Joshua A. Lile - Publications

Affiliations: 
University of Kentucky, Lexington, KY 

61/114 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Regnier SD, Shellenberg TP, Koffarnus MN, Cox DH, Lile JA, Rush CR, Stoops WW. Cocaine abstinence during the "critical period" of a contingency management trial predicts future abstinence in people with cocaine use disorder. Drug and Alcohol Dependence. 253: 111030. PMID 38006674 DOI: 10.1016/j.drugalcdep.2023.111030  0.546
2023 Strickland JC, Hatton KW, Hays LR, Rayapati AO, Lile JA, Rush CR, Stoops WW. Use of drug purchase tasks in medications development research: orexin system regulation of cocaine and drug demand. Behavioural Pharmacology. 34: 275-286. PMID 37403694 DOI: 10.1097/FBP.0000000000000731  0.658
2023 Regnier SD, Stoops WW, Lile JA, Alcorn JL, Bolin BL, Reynolds AR, Hays LR, Rayapati AO, Rush CR. Naltrexone-bupropion combinations do not affect cocaine self-administration in humans. Pharmacology, Biochemistry, and Behavior. 224: 173526. PMID 36805862 DOI: 10.1016/j.pbb.2023.173526  0.718
2022 Stoops WW, Strickland JC, Hatton KW, Hays LR, Rayapati AO, Lile JA, Rush CR. Suvorexant maintenance enhances the reinforcing but not subjective and physiological effects of intravenous cocaine in humans. Pharmacology, Biochemistry, and Behavior. 220: 173466. PMID 36152876 DOI: 10.1016/j.pbb.2022.173466  0.77
2022 Regnier SD, Lile JA, Rush CR, Stoops WW. Clinical neuropharmacology of cocaine reinforcement: A narrative review of human laboratory self-administration studies. Journal of the Experimental Analysis of Behavior. PMID 35229294 DOI: 10.1002/jeab.744  0.703
2020 Rush CR, Stoops WW, Lile JA, Alcorn JL, Bolin BL, Reynolds AR, Hays LR, Rayapati AO. Topiramate-phentermine combinations reduce cocaine self-administration in humans. Drug and Alcohol Dependence. 218: 108413. PMID 33290875 DOI: 10.1016/j.drugalcdep.2020.108413  0.653
2020 Shellenberg TP, Stoops WW, Lile JA, Rush CR. An update on the clinical pharmacology of methylphenidate: therapeutic efficacy, abuse potential and future considerations. Expert Review of Clinical Pharmacology. 1-9. PMID 32715789 DOI: 10.1080/17512433.2020.1796636  0.463
2020 Alcorn JL, Strickland JC, Lile JA, Stoops WW, Rush CR. Acute methylphenidate administration reduces cocaine-cue attentional bias. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 109974. PMID 32454161 DOI: 10.1016/J.Pnpbp.2020.109974  0.674
2019 Lile JA, Johnson AR, Banks ML, Hatton KW, Hays LR, Nicholson KL, Poklis JL, Rayapati AO, Rush CR, Stoops WW, Negus SS. Pharmacological validation of a translational model of cocaine use disorder: Effects of d-amphetamine maintenance on choice between intravenous cocaine and a nondrug alternative in humans and rhesus monkeys. Experimental and Clinical Psychopharmacology. PMID 31259593 DOI: 10.1037/Pha0000302  0.778
2019 Stoops WW, Strickland JC, Alcorn JL, Hays LR, Rayapati AO, Lile JA, Rush CR. Influence of phendimetrazine maintenance on the reinforcing, subjective, performance, and physiological effects of intranasal cocaine. Psychopharmacology. PMID 30900008 DOI: 10.1007/S00213-019-05227-X  0.74
2018 Alcorn JL, Marks KR, Stoops WW, Rush CR, Lile JA. Attentional bias to cannabis cues in cannabis users but not cocaine users. Addictive Behaviors. 88: 129-136. PMID 30176501 DOI: 10.1016/J.Addbeh.2018.08.023  0.316
2018 Strickland JC, Marks KR, Beckmann JS, Lile JA, Rush CR, Stoops WW. Contribution of cocaine-related cues to concurrent monetary choice in humans. Psychopharmacology. PMID 30046863 DOI: 10.1007/S00213-018-4978-5  0.4
2017 Reynolds AR, Strickland JC, Stoops WW, Lile JA, Rush CR. Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine. Drug and Alcohol Dependence. 181: 25-29. PMID 29028556 DOI: 10.1016/J.Drugalcdep.2017.08.038  0.33
2017 Bolin BL, Alcorn JL, Lile JA, Rush CR, Rayapati AO, Hays LR, Stoops WW. N-Acetylcysteine reduces cocaine-cue attentional bias and differentially alters cocaine self-administration based on dosing order. Drug and Alcohol Dependence. 178: 452-460. PMID 28711811 DOI: 10.1016/J.Drugalcdep.2017.05.039  0.733
2017 Alcorn JL, Pike E, Stoops WS, Lile JA, Rush CR. A pilot investigation of acute inhibitory control training in cocaine users. Drug and Alcohol Dependence. 174: 145-149. PMID 28329718 DOI: 10.1016/J.Drugalcdep.2017.01.014  0.57
2017 Stoops WW, Lile JA, Hays LR, Rayapati AO, Rush CR. Safety and tolerability of cocaine during phendimetrazine maintenance Drug and Alcohol Dependence. 171: e197-e198. DOI: 10.1016/J.Drugalcdep.2016.08.540  0.657
2017 Alcorn JL, Pike E, Lile JA, Stoops WW, Rush CR. Acute inhibitory control training in cocaine users Drug and Alcohol Dependence. 171: e5. DOI: 10.1016/J.Drugalcdep.2016.08.029  0.516
2016 Strickland JC, Lile JA, Rush CR, Stoops WW. Comparing exponential and exponentiated models of drug demand in cocaine users. Experimental and Clinical Psychopharmacology. 24: 447-455. PMID 27929347 DOI: 10.1037/Pha0000096  0.468
2016 Harvanko A, Martin C, Lile J, Kryscio R, Kelly TH. Individual differences in the reinforcing and subjective effects of d-amphetamine: Dimensions of impulsivity. Experimental and Clinical Psychopharmacology. 24: 436-446. PMID 27929346 DOI: 10.1037/Pha0000095  0.331
2016 Strickland JC, Bolin BL, Lile JA, Rush CR, Stoops WW. Differential sensitivity to learning from positive and negative outcomes in cocaine users. Drug and Alcohol Dependence. PMID 27373186 DOI: 10.1016/J.Drugalcdep.2016.06.022  0.403
2016 Lile JA, Stoops WW, Rush CR, Negus SS, Glaser PE, Hatton KW, Hays LR. Development of a translational model to screen medications for cocaine use disorder II: Choice between intravenous cocaine and money in humans. Drug and Alcohol Dependence. PMID 27269368 DOI: 10.1016/J.Drugalcdep.2016.05.022  0.607
2016 Johnson AR, Banks ML, Blough BE, Lile JA, Nicholson KL, Negus SS. Development of a translational model to screen medications for cocaine use disorder I: Choice between cocaine and food in rhesus monkeys. Drug and Alcohol Dependence. PMID 27264165 DOI: 10.1016/j.drugalcdep.2016.05.021  0.748
2016 Bolin BL, Lile JA, Marks KR, Beckmann JS, Rush CR, Stoops WW. Buspirone reduces sexual risk-taking intent but not cocaine self-administration. Experimental and Clinical Psychopharmacology. 24: 162-73. PMID 27254258 DOI: 10.1037/Pha0000076  0.608
2016 Marks KR, Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR. Separate and Combined Effects of Naltrexone and Extended-Release Alprazolam on the Reinforcing, Subject-Rated, and Cardiovascular Effects of Methamphetamine. Journal of Clinical Psychopharmacology. PMID 27043121 DOI: 10.1097/Jcp.0000000000000488  0.342
2016 Stoops WW, Strickland JC, Hays LR, Rayapati AO, Lile JA, Rush CR. Safety and tolerability of intranasal cocaine during phendimetrazine maintenance. Psychopharmacology. PMID 26932737 DOI: 10.1007/S00213-016-4260-7  0.71
2015 Bolin BL, Lile JA, Marks KR, Rush CR, Stoops WW. Influence of buspirone maintenance on the pharmacodynamic effects of cocaine and sexual risk taking in cocaine users Drug and Alcohol Dependence. 156: e23. DOI: 10.1016/J.Drugalcdep.2015.07.981  0.645
2015 Lile JA, Negus S, Stoops WW, Johnson A, Kate N, Banks M, Rush CR, Hays L, Glaser P. Coordinated and homologous intravenous cocaine self-administration procedures in monkeys and humans: A translational approach to medications development Drug and Alcohol Dependence. 156: e129. DOI: 10.1016/J.Drugalcdep.2015.07.354  0.596
2014 Strickland JC, Lile JA, Rush CR, Stoops WW. Relationship between intranasal cocaine self-administration and subject-rated effects: predictors of cocaine taking on progressive-ratio schedules. Human Psychopharmacology. 29: 342-50. PMID 25163439 DOI: 10.1002/Hup.2409  0.563
2013 Stoops WW, Bennett JA, Lile JA, Sevak RJ, Rush CR. Influence of aripiprazole pretreatment on the reinforcing effects of methamphetamine in humans. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 47: 111-7. PMID 23994622 DOI: 10.1016/J.Pnpbp.2013.08.007  0.337
2013 Lile JA, Charnigo RJ, Nader MA. The relative reinforcing strength of methamphetamine and D-amphetamine in monkeys self-administering cocaine. Behavioural Pharmacology. 24: 482-5. PMID 23907377 DOI: 10.1097/Fbp.0B013E3283644D44  0.751
2012 Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR. Influence of acute bupropion pre-treatment on the effects of intranasal cocaine. Addiction (Abingdon, England). 107: 1140-7. PMID 22168398 DOI: 10.1111/J.1360-0443.2011.03766.X  0.717
2012 Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR. Alternative reinforcer response cost impacts cocaine choice in humans. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 36: 189-93. PMID 22015480 DOI: 10.1016/J.Pnpbp.2011.10.003  0.711
2011 Rush CR, Stoops WW, Lile JA, Glaser PE, Hays LR. Physiological and subjective effects of acute intranasal methamphetamine during atomoxetine maintenance. Pharmacology, Biochemistry, and Behavior. 100: 40-7. PMID 21802442 DOI: 10.1016/J.Pbb.2011.06.024  0.352
2011 Rush CR, Stoops WW, Lile JA, Glaser PE, Hays LR. Subjective and physiological effects of acute intranasal methamphetamine during d-amphetamine maintenance. Psychopharmacology. 214: 665-74. PMID 21072503 DOI: 10.1007/S00213-010-2067-5  0.365
2011 Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR. Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans. Journal of Psychopharmacology (Oxford, England). 25: 1469-79. PMID 20952456 DOI: 10.1177/0269881110385597  0.719
2011 Lile JA, Babalonis S, Emurian C, Martin CA, Wermeling DP, Kelly TH. Comparison of the behavioral and cardiovascular effects of intranasal and oral d-amphetamine in healthy human subjects. Journal of Clinical Pharmacology. 51: 888-98. PMID 20671295 DOI: 10.1177/0091270010375956  0.338
2010 Stoops WW, Lile JA, Glaser PE, Hays LR, Rush CR. Intranasal cocaine functions as reinforcer on a progressive ratio schedule in humans. European Journal of Pharmacology. 644: 101-5. PMID 20638380 DOI: 10.1016/J.Ejphar.2010.06.055  0.769
2010 Stoops WW, Lile JA, Rush CR. Monetary alternative reinforcers more effectively decrease intranasal cocaine choice than food alternative reinforcers. Pharmacology, Biochemistry, and Behavior. 95: 187-91. PMID 20109483 DOI: 10.1016/J.Pbb.2010.01.003  0.726
2008 Lile JA, Stoops WW, Hays LR, Rush CR. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period. The American Journal of Drug and Alcohol Abuse. 34: 721-9. PMID 18855244 DOI: 10.1080/00952990802308262  0.717
2007 Stoops WW, Lile JA, Lofwall MR, Rush CR. The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance. The American Journal of Drug and Alcohol Abuse. 33: 769-76. PMID 17994473 DOI: 10.1080/00952990701651556  0.726
2007 Lile JA, Kendall SL, Babalonis S, Martin CA, Kelly TH. Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women. Pharmacology, Biochemistry, and Behavior. 87: 258-66. PMID 17544491 DOI: 10.1016/j.pbb.2007.04.022  0.317
2007 Stoops WW, Vansickel AR, Lile JA, Rush CR. Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans. Pharmacology, Biochemistry, and Behavior. 87: 20-9. PMID 17490738 DOI: 10.1016/J.Pbb.2007.03.016  0.508
2007 Stoops WW, Lile JA, Robbins CG, Martin CA, Rush CR, Kelly TH. The reinforcing, subject-rated, performance, and cardiovascular effects of d-amphetamine: influence of sensation-seeking status. Addictive Behaviors. 32: 1177-88. PMID 17011712 DOI: 10.1016/J.Addbeh.2006.08.006  0.359
2006 Lile JA, Stoops WW, Durell TM, Glaser PE, Rush CR. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans. Experimental and Clinical Psychopharmacology. 14: 136-47. PMID 16756417 DOI: 10.1037/1064-1297.14.2.136  0.391
2006 Claytor R, Lile JA, Nader MA. The effects of eticlopride and the selective D3-antagonist PNU 99194-A on food- and cocaine-maintained responding in rhesus monkeys. Pharmacology, Biochemistry, and Behavior. 83: 456-64. PMID 16631246 DOI: 10.1016/J.Pbb.2006.03.007  0.737
2006 Stoops WW, Lile JA, Glaser PE, Rush CR. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine. Drug and Alcohol Dependence. 84: 206-9. PMID 16540264 DOI: 10.1016/J.Drugalcdep.2006.02.004  0.484
2006 Lile JA. Pharmacological determinants of the reinforcing effects of psychostimulants: relation to agonist substitution treatment. Experimental and Clinical Psychopharmacology. 14: 20-33. PMID 16503702 DOI: 10.1037/1064-1297.14.1.20  0.428
2005 Lile JA, Stoops WW, Wagner FP, Glaser PE, Rush CR. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans. Pharmacology, Biochemistry, and Behavior. 82: 270-9. PMID 16182353 DOI: 10.1016/J.Pbb.2005.08.012  0.323
2005 Lile JA, Stoops WW, Vansickel AR, Glaser PE, Hays LR, Rush CR. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 2103-14. PMID 15988473 DOI: 10.1038/Sj.Npp.1300803  0.435
2005 Stoops WW, Lile JA, Fillmore MT, Glaser PE, Rush CR. Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology. 182: 186-93. PMID 15986191 DOI: 10.1007/S00213-005-0044-1  0.322
2005 Lile JA, Ross JT, Nader MA. A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys. Drug and Alcohol Dependence. 78: 135-40. PMID 15845316 DOI: 10.1016/J.Drugalcdep.2004.10.006  0.784
2005 Stoops WW, Lile JA, Glaser PE, Rush CR. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans. Experimental and Clinical Psychopharmacology. 13: 56-64. PMID 15727504 DOI: 10.1037/1064-1297.13.1.56  0.375
2005 Stoops WW, Lile JA, Fillmore MT, Glaser PE, Rush CR. Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacology. 177: 349-55. PMID 15609070 DOI: 10.1007/S00213-004-1946-Z  0.53
2004 Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR. Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans. Drug and Alcohol Dependence. 76: 81-91. PMID 15380292 DOI: 10.1016/J.Drugalcdep.2004.04.010  0.75
2004 Lile JA, Morgan D, Birmingham AM, Davies HM, Nader MA. Effects of the dopamine reuptake inhibitor PTT on reinstatement and on food- and cocaine-maintained responding in rhesus monkeys. Psychopharmacology. 174: 246-53. PMID 14735291 DOI: 10.1007/S00213-003-1738-X  0.765
2004 Lile JA, Stoops WW, Allen TS, Glaser PE, Hays LR, Rush CR. Baclofen does not alter the reinforcing, subject-rated or cardiovascular effects of intranasal cocaine in humans. Psychopharmacology. 171: 441-9. PMID 14504683 DOI: 10.1007/S00213-003-1598-4  0.761
2003 Lile JA, Wang Z, Woolverton WL, France JE, Gregg TC, Davies HM, Nader MA. The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics. The Journal of Pharmacology and Experimental Therapeutics. 307: 356-66. PMID 12954808 DOI: 10.1124/Jpet.103.049825  0.745
2002 Lile JA, Morgan D, Birmingham AM, Wang Z, Woolverton WL, Davies HM, Nader MA. The reinforcing efficacy of the dopamine reuptake inhibitor 2beta-propanoyl-3beta-(4-tolyl)-tropane (PTT) as measured by a progressive-ratio schedule and a choice procedure in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 303: 640-8. PMID 12388646 DOI: 10.1124/Jpet.102.039180  0.799
2000 Lile JA, Morgan D, Freedland CS, Sinnott RS, Davies HM, Nader MA. Self-administration of two long-acting monoamine transport blockers in rhesus monkeys. Psychopharmacology. 152: 414-21. PMID 11140334 DOI: 10.1007/S002130000554  0.773
2000 Lile JA, Morgan D, Nader MA. First- versus last-session substitution: an evaluation of the reinforcing effects of cocaine and the cocaine analogue 2beta-propanoyl-3beta-(4-tolyl)-tropane. Experimental and Clinical Psychopharmacology. 8: 424-33. PMID 10975634 DOI: 10.1037//1064-1297.8.3.424  0.784
1999 Lile JA. AN ALTERATION IN THE SELF-ADMINISTRATION OF TWO NOVEL TROPANE ANALOGS IN RHESUS MONKEYS FOLLOWING COCAINE EXPOSURE Behavioural Pharmacology. 10: S58. DOI: 10.1097/00008877-199908001-00146  0.659
Low-probability matches (unlikely to be authored by this person)
2010 Lile JA, Kelly TH, Hays LR. Substitution profile of the cannabinoid agonist nabilone in human subjects discriminating δ9-tetrahydrocannabinol. Clinical Neuropharmacology. 33: 235-42. PMID 20838217 DOI: 10.1097/WNF.0b013e3181e77428  0.3
2009 Lile JA, Kelly TH, Pinsky DJ, Hays LR. Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol. Psychopharmacology. 203: 241-50. PMID 19018520 DOI: 10.1007/s00213-008-1393-3  0.295
2021 Smith AP, Kelly TH, Lile JA, Martin CA, Ramirez MP, Wesley MJ. Exploratory examination of the effects of d-amphetamine on active-state functional connectivity: Influence of impulsivity and sensation-seeking status. Experimental and Clinical Psychopharmacology. PMID 33764102 DOI: 10.1037/pha0000406  0.285
2011 Lile JA, Kelly TH, Hays LR. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC. Drug and Alcohol Dependence. 116: 86-92. PMID 21227600 DOI: 10.1016/j.drugalcdep.2010.11.019  0.285
2014 Marks KR, Lile JA, Stoops WW, Rush CR. Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users. Psychopharmacology. 231: 2741-50. PMID 24464531 DOI: 10.1007/S00213-014-3449-X  0.274
2018 Wesley MJ, Westgate PM, Stoops WW, Kelly TH, Hays LR, Lile JA. Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users. Experimental and Clinical Psychopharmacology. 26: 310-319. PMID 29863387 DOI: 10.1037/Pha0000180  0.265
2019 Strickland JC, Lile JA, Stoops WW. Contribution of cannabis-related cues to concurrent reinforcer choice in humans. Drug and Alcohol Dependence. 199: 85-91. PMID 31029879 DOI: 10.1016/j.drugalcdep.2019.02.022  0.262
2015 Lile JA, Wesley MJ, Kelly TH, Hays LR. Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocananbinol in humans discriminating [INCREMENT]9-tetrahydrocananbinol. Behavioural Pharmacology. PMID 26313650 DOI: 10.1097/Fbp.0000000000000187  0.262
2017 Wesley MJ, Lile JA, Emurian C, Martin C, Joseph J, Kelly T. Striatal responses to d-amphetamine differentiates young adults at “high-risk” of drug abuse Drug and Alcohol Dependence. 171: e216. DOI: 10.1016/J.Drugalcdep.2016.08.591  0.256
2011 Babalonis S, Lile JA, Martin CA, Kelly TH. Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women. Psychopharmacology. 215: 429-39. PMID 21350928 DOI: 10.1007/s00213-011-2206-7  0.254
2007 Vansickel AR, Lile JA, Stoops WW, Rush CR. Similar discriminative-stimulus effects of D-amphetamine in women and men. Pharmacology, Biochemistry, and Behavior. 87: 289-96. PMID 17561238 DOI: 10.1016/J.Pbb.2007.05.003  0.25
2011 Lile JA, Stoops WW, Glaser PE, Hays LR, Rush CR. Physiological and subjective effects of acute intranasal methamphetamine during extended-release alprazolam maintenance. Drug and Alcohol Dependence. 119: 187-93. PMID 21737214 DOI: 10.1016/J.Drugalcdep.2011.06.006  0.244
2011 Babalonis S, Lile JA, Martin CA, Kelly TH. Progesterone effects on the discriminative stimulus, subjective and performance effects of triazolam in healthy, premenopausal women. Behavioural Pharmacology. 22: 441-9. PMID 21808190 DOI: 10.1097/FBP.0b013e328349fc02  0.239
2012 Lile JA, Kelly TH, Hays LR. Separate and combined effects of the GABA reuptake inhibitor tiagabine and Δ9-THC in humans discriminating Δ9-THC. Drug and Alcohol Dependence. 122: 61-9. PMID 21975195 DOI: 10.1016/j.drugalcdep.2011.09.010  0.233
2013 Lile JA, Kelly TH, Charnigo RJ, Stinchcomb AL, Hays LR. Pharmacokinetic and pharmacodynamic profile of supratherapeutic oral doses of Δ(9) -THC in cannabis users. Journal of Clinical Pharmacology. 53: 680-90. PMID 23754596 DOI: 10.1002/Jcph.90  0.226
2010 Lile JA, Kelly TH, Hays LR. The reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users. Behavioural Pharmacology. 21: 29-38. PMID 19949319 DOI: 10.1097/FBP.0b013e32833470d7  0.223
2015 Harvanko AM, Martin C, Charnigo RJ, Fogel JS, Lile JA, Kelly T. Predicting the effects of d-amphetamine using measures of sensation seeking and impulsivity Drug and Alcohol Dependence. 146: e137-e138. DOI: 10.1016/J.Drugalcdep.2014.09.292  0.221
2016 Fogel JS, Kelly TH, Westgate PM, Lile JA. Sex differences in the subjective effects of oral Δ9-THC in cannabis users. Pharmacology, Biochemistry, and Behavior. PMID 26780348 DOI: 10.1016/j.pbb.2016.01.007  0.217
2015 Fogel JS, Kelly T, Harvanko AM, Lile J. Effects of repeated cue exposure on cannabis craving Drug and Alcohol Dependence. 156: e71. DOI: 10.1016/J.DRUGALCDEP.2015.07.1111  0.214
2015 Kelly T, Anderson A, Jenkins S, Harvanko AM, Martin C, Fogel JS, Joseph J, Lile JA. d-Amphetamine effects and monetary incentive delay task performance: An fMRI study Drug and Alcohol Dependence. 146: e156. DOI: 10.1016/J.Drugalcdep.2014.09.341  0.21
2021 Lile JA, Alcorn JL, Hays LR, Kelly TH, Stoops WW, Wesley MJ, Westgate PM. Influence of pregabalin maintenance on cannabis effects and related behaviors in daily cannabis users. Experimental and Clinical Psychopharmacology. PMID 33983765 DOI: 10.1037/pha0000464  0.209
2023 Wesley MJ, Lile JA. Combining noninvasive brain stimulation with behavioral pharmacology methods to study mechanisms of substance use disorder. Frontiers in Neuroscience. 17: 1150109. PMID 37554294 DOI: 10.3389/fnins.2023.1150109  0.194
2015 Marks KR, Lemons A, Stoops WW, Lile JA, Rush CR. Laboratory drug administration does not increase use in the natural ecology immediately following study discharge Drug and Alcohol Dependence. 156: e140. DOI: 10.1016/J.Drugalcdep.2015.07.382  0.188
2017 Reynolds AR, Stoops WW, Lile JA, Rush CR. The influence of buspirone maintenance on the pharmacodynamic effects of methamphetamine Drug and Alcohol Dependence. 171: e175. DOI: 10.1016/J.Drugalcdep.2016.08.481  0.187
2016 Bolin BL, Alcorn JL, Reynolds AR, Lile JA, Stoops WW, Rush CR. Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs. Current Topics in Behavioral Neurosciences. PMID 27272070 DOI: 10.1007/7854_2016_10  0.178
2024 Lile JA, Shellenberg TP, Babalonis S, Hatton KW, Hays LR, Rayapati AO, Stoops WW, Wesley MJ. A dose-ranging study of the physiological and self-reported effects of repeated, rapid infusion of remifentanil in people with opioid use disorder and physical dependence on fentanyl. Psychopharmacology. PMID 38383903 DOI: 10.1007/s00213-024-06557-1  0.171
2014 Lile JA, Kelly T, Hays L. Separate and combined effects of gabapentin and Δ9-THC doses in cannabis users discriminating Δ9-THC Drug and Alcohol Dependence. 140: e123. DOI: 10.1016/J.DRUGALCDEP.2014.02.352  0.163
2008 Babalonis S, Emurian CS, Martin CA, Lile JA, Kelly TH. Modulation of the discriminative stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women. Drug and Alcohol Dependence. 94: 276-80. PMID 18178039 DOI: 10.1016/j.drugalcdep.2007.11.007  0.153
2016 Bolin BL, Alcorn JL, Reynolds AR, Lile JA, Rush CR. Human drug discrimination: A primer and methodological review. Experimental and Clinical Psychopharmacology. 24: 214-28. PMID 27454673 DOI: 10.1037/Pha0000077  0.147
2012 Lile JA, Kelly TH, Hays LR. Separate and combined effects of the GABA(B) agonist baclofen and Δ9-THC in humans discriminating Δ9-THC. Drug and Alcohol Dependence. 126: 216-23. PMID 22699093 DOI: 10.1016/j.drugalcdep.2012.05.023  0.143
2014 Lile JA, Kelly TH, Hays LR. Separate and combined effects of the GABAA positive allosteric modulator diazepam and Δ⁹-THC in humans discriminating Δ⁹-THC. Drug and Alcohol Dependence. 143: 141-8. PMID 25124305 DOI: 10.1016/j.drugalcdep.2014.07.016  0.139
2023 Tolbert PT, Ramirez MP, Strickland JC, Lile JA, Stoops WW, Stamper BJ, Sumner CB, Wesley MJ. Exponentiated model of drug demand is preferred over exponential models in people with daily/near daily cannabis use. Experimental and Clinical Psychopharmacology. PMID 37126035 DOI: 10.1037/pha0000652  0.125
2005 Rush CR, Higgins ST, Vansickel AR, Stoops WW, Lile JA, Glaser PE. Methylphenidate increases cigarette smoking. Psychopharmacology. 181: 781-9. PMID 15983792 DOI: 10.1007/S00213-005-0021-8  0.12
2019 Strickland JC, Lile JA, Stoops WW. Evaluating non-medical prescription opioid demand using commodity purchase tasks: test-retest reliability and incremental validity. Psychopharmacology. PMID 30927021 DOI: 10.1007/S00213-019-05234-Y  0.118
2022 Turner BW, Cox DH, Shellenberg TP, Katz NR, Lundie BA, Lile JA, Stoops WW, Rush CR. Differential impacts of economic and demographic variables on substance use patterns during the COVID-19 pandemic. The American Journal of Drug and Alcohol Abuse. 1-10. PMID 35166629 DOI: 10.1080/00952990.2021.1984492  0.116
2015 Lile J, Kelly T, Stoops W, Fogel J, Harvanko A, Charnigo R, Hays L. Cannabis self-administration in the laboratory and use in the natural environment during outpatient tiagabine maintenance Drug and Alcohol Dependence. 146: e180. DOI: 10.1016/J.Drugalcdep.2014.09.405  0.109
2020 Stoops WW, Strickland JC, Hays LR, Rayapati AO, Lile JA, Rush CR. Influence of n-acetylcysteine maintenance on the pharmacodynamic effects of oral ethanol. Pharmacology, Biochemistry, and Behavior. 173037. PMID 32891709 DOI: 10.1016/J.Pbb.2020.173037  0.108
2021 Kumar M, Rainville JR, Williams K, Lile JA, Hodes GE, Vassoler FM, Turner JR. Sexually Dimorphic Neuroimmune Response to Chronic Opioid Treatment and Withdrawal. Neuropharmacology. 108469. PMID 33485944 DOI: 10.1016/j.neuropharm.2021.108469  0.098
2022 Lile JA, Turner BW, Cox DH, Bonn-Miller MO, Katz NR, Shellenberg TP, Stoops WW, Strickland JC. Cannabis Use Disorder Treatment Preferences: A Pilot Survey in Current Users of Cannabis. Journal of Addiction Medicine. PMID 36731101 DOI: 10.1097/ADM.0000000000001059  0.094
2013 Joseph JE, Kelly TH, Lile JA. The Neurobiological Basis of Personality Risk for Addiction Biological Research On Addiction. 401-412. DOI: 10.1016/B978-0-12-398335-0.00040-6  0.081
2019 Strickland JC, Campbell EM, Lile JA, Stoops WW. Utilizing the Commodity Purchase Task to Evaluate Behavioral Economic Demand for Illicit Substances: A Review and Meta-Analysis. Addiction (Abingdon, England). PMID 31454109 DOI: 10.1111/Add.14792  0.076
2020 Loflin MJE, Kiluk BD, Huestis MA, Aklin WM, Budney AJ, Carroll KM, D'Souza DC, Dworkin RH, Gray KM, Hasin DS, Lee DC, Le Foll B, Levin FR, Lile JA, Mason BJ, et al. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug and Alcohol Dependence. 107993. PMID 32360455 DOI: 10.1016/J.Drugalcdep.2020.107993  0.07
2009 Budney AJ, Lile JA. Moving beyond the cannabis controversy into the world of the cannabinoids. International Review of Psychiatry (Abingdon, England). 21: 91-5. PMID 19367502 DOI: 10.1080/09540260902782729  0.068
2017 Strickland JC, Lile JA, Stoops WW. Unique Prediction of Cannabis Use Severity and Behaviors by Delay Discounting and Behavioral Economic Demand. Behavioural Processes. PMID 28347716 DOI: 10.1016/J.Beproc.2017.03.017  0.066
2015 Wesley MJ, Lile JA, Hanlon CA, Porrino LJ. Abnormal medial prefrontal cortex activity in heavy cannabis users during conscious emotional evaluation. Psychopharmacology. PMID 26690589 DOI: 10.1007/S00213-015-4180-Y  0.062
2015 Harvanko A, Martin C, Fogel JS, Lile J, Kelly T. A comparison of the behavioral effects of electronic and tobacco cigarettes following 24-h tobacco deprivation Drug and Alcohol Dependence. 156: e92. DOI: 10.1016/J.DRUGALCDEP.2015.07.1167  0.058
2015 Wesley M, Lile J, Emurian C, Martin C, Joseph J, Kelly T. Classification of drug and placebo with functional magnetic resonance imaging Drug and Alcohol Dependence. 156: e237-e238. DOI: 10.1016/J.Drugalcdep.2015.07.640  0.051
2014 Martin CA, Lile J, Guenthner G, Anestis JC, Batten SR, Kelly TH. Behavioral effects of modafinil and nicotine, alone and in combination, in tobacco-deprived young adult smokers. Journal of Clinical Psychopharmacology. 34: 278-81. PMID 24525639 DOI: 10.1097/Jcp.0000000000000080  0.05
2015 Fogel J, Kelly T, Charnigo R, Harvanko A, Lile J. Predictors of the response to oral ΢9-THC in regular cannabis users: Focus on sex differences Drug and Alcohol Dependence. 146: e279-e280. DOI: 10.1016/J.Drugalcdep.2014.09.226  0.042
2017 Harvanko AM, Martin CA, Kryscio RJ, Stoops WW, Lile JA, Kelly TH. A Prototypical First-Generation Electronic Cigarette Does Not Reduce Reports of Tobacco Urges or Withdrawal Symptoms among Cigarette Smokers. Journal of Addiction. 2017: 6748948. PMID 28458942 DOI: 10.1155/2017/6748948  0.041
2017 Wesley MJ, Lile JA, Fillmore MT, Porrino LJ. Neurophysiological capacity in a working memory task differentiates dependent from nondependent heavy drinkers and controls. Drug and Alcohol Dependence. 175: 24-35. PMID 28376413 DOI: 10.1016/J.Drugalcdep.2017.01.029  0.035
2015 Kelly T, Wesley M, Emurian C, Martin C, Joseph J, Lile J. Positive association between cingulate brain volume and sensation seeking in young adults Drug and Alcohol Dependence. 156: e107. DOI: 10.1016/J.Drugalcdep.2015.07.297  0.034
1993 Keeling MM, Schmidt-Clay P, Kotcamp WW, Lile JA, Watson AK. Autotransfusion in the postoperative orthopedic patient. Clinical Orthopaedics and Related Research. 251-8. PMID 8504608  0.023
Hide low-probability matches.